Home
Deep Track Capital reported a 4.37% stake in enGene Therapeutics ENGN · 2,239,353 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.37%
- Last report
- 8.94% · filed 25/02/14
- Shares held
- 2,239,353 sh
- Class
- Common Shares
- Holder
- Deep Track Capital
- Event date
- 25/09/30
- Filed
- 25/11/14
4.37% stake · below 5%
- Stake
- 4.37%
- Last report
- 8.94%
- Since last report
- −4.6pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Deep Track Capital's other 5% stake reports
- Deep Track Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.83% stake
450,000 sh
5.83% stake
Filed 09/02
- Deep Track Capital
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
7.45% stake
7,736,455 sh
7.45% stake
Filed 08/14
- Deep Track Capital
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
8.33% stake
8,040,894 sh
8.33% stake
Filed 08/14
- Deep Track Capital
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
3.25% stake
3,592,740 sh
3.25% stake
Filed 08/14
- Deep Track Capital
5% stakePersonalis
5% stakePersonalis
PSNL
3.82% stake
4,000,000 sh
3.82% stake
Filed 08/14
